参考文献/References:
[1] 中国抗癌协会神经内分泌肿瘤专业委员会. 中国抗癌协会神经内分泌肿瘤诊治指南(2022年版). 中国癌症杂志, 2022, 32(6):545-580.
[2] Rinke A, Ambrosini V, Dromain C, et al. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours. J Neuroendocrinol, 2023, 35(6):e13309.
[3] National Comprehensive Cancer Network Neuroendocrine and Adrenal Tumors. Version 2.2024. [https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf](https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf)
[4] Rindi G, Inzani F. Neuroendocrine neoplasm update: toward universal nomenclature. Endocr Relat Cancer, 2020, 27(6):R211-R218.
[5] Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol, 2017, 3(10):1335.
[6] Fan JH, Zhang YQ, Shi SS, et al. A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in China. Oncotarget, 2017, 8(42):71699-71708.
[7] Chi Y, Liu S, Zhang J, et al. Epidemiological characteristics of neuroendocrine neoplasms in Beijing: a population-based retrospective study. BMC Public Health, 2024, 24(1):1396.
[8] Volante M, Grillo F, Massa F, et al. Neuroendocrine neoplasms of the appendix, colon and rectum. Pathologica, 2021, 113(1):19-27.
[9] Basuroy R, Haji A, Ramage JK, et al. Review article: the investigation and management of rectal neuroendocrine tumours. Aliment Pharmacol Ther, 2016, 44(4):332-345.
[10] Zhou X, Xie H, Xie L, et al. Factors associated with lymph node metastasis in radically resected rectal carcinoids: a systematic review and meta-analysis. J Gastrointest Surg, 2013, 17(9):1689-1697.
[11] 雷天霞, 王海星, 刘香, 等. 微探头内镜超声在直径≤1cm的直肠神经内分泌瘤内镜治疗中的应用价值. 中国医科大学学报, 2020, 49(8):757-760.
[12] Lee HS, Moon HS, Kwon IS, et al. Comparison of conventional and modified endoscopic mucosal resection methods for the treatment of rectal neuroendocrine tumors. Surg Endosc, 2021, 35(11):6055-6065.
[13] Im YC, Jung SW, Cha HJ, et al. The effectiveness of endoscopic submucosal resection with a ligation device for small rectal carcinoid tumors: focused on previously biopsied tumors. Surg Laparosc Endosc Percutan Tech, 2014, 24(3):264-269.
[14] Yang DH, Park Y, Park SH, et al. Cap-assisted EMR for rectal neuroendocrine tumors: comparisons with conventional EMR and endoscopic submucosal dissection (with videos). Gastrointest Endosc, 2016, 83(5):1015-1022.
[15] Lee J, Park YE, Choi JH, et al. Comparison between cap-assisted and ligation-assisted endoscopic mucosal resection for rectal neuroendocrine tumors. Ann Gastroenterol, 2020, 33(4):385-390.
[16] Lim HK, Lee SJ, Baek DH, et al. Resectability of rectal neuroendocrine tumors using endoscopic mucosal resection with a ligation band device and endoscopic submucosal dissection. Gastroenterol Res Pract, 2019, 2019:8425157.
[17] Gao X, Huang S, Wang Y, et al. Modified cap-assisted endoscopic mucosal resection versus endoscopic submucosal dissection for the treatment of rectal neuroendocrine tumors ≤10 mm: a randomized noninferiority trial. Am J Gastroenterol, 2022, 117(12):1982-1989.
[18] Chen R, Liu X, Sun S, et al. Comparison of endoscopic mucosal resection with circumferential incision and endoscopic submucosal dissection for rectal carcinoid tumor. Surg Laparosc Endosc Percutan Tech, 2016, 26(3):e56-e61.
[19] Yong JN, Lim XC, Nistala KRY, et al. Endoscopic submucosal dissection versus endoscopic mucosal resection for rectal carcinoid tumor. A meta-analysis and meta-regression with single-arm analysis. J Dig Dis, 2021, 22(10):562-571.
[20] Wang XY, Chai NL, Linghu EQ, et al. Efficacy and safety of hybrid endoscopic submucosal dissection compared with endoscopic submucosal dissection for rectal neuroendocrine tumors and risk factors associated with incomplete endoscopic resection. Ann Transl Med, 2020, 8(6):368.
[21] Meier B, Albrecht H, Wiedbrauck T, et al. Full-thickness resection of neuroendocrine tumors in the rectum. Endoscopy, 2020, 52(1):68-72.
[22] Brand M, Reimer S, Reibetanz J, et al. Endoscopic full thickness resection vs. transanal endoscopic microsurgery for local treatment of rectal neuroendocrine tumors: a retrospective analysis. Int J Colorectal Dis, 2021, 36(5):971-976.
[23] Tribonias G, Komeda Y, Leontidis N, et al. Endoscopic intermuscular dissection (EID) for removing early rectal cancers and benign fibrotic rectal lesions. Tech Coloproctolo, 2023, 27(12):1393-1400.
[24] Sun P, Zheng T, Hu C, et al. Comparison of endoscopic therapies for rectal neuroendocrine tumors: endoscopic submucosal dissection with myectomy versus endoscopic submucosal dissection. Surg Endosc, 2021, 35(11):6374-6378.
[25] Cha B, Shin J, Ko WJ, et al. Prognosis of incompletely resected small rectal neuroendocrine tumor using endoscope without additional treatment. BMC Gastroenterol, 2022, 22(1):293.